Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stephens, R. H.
Right arrow Articles by Gibson, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stephens, R. H.
Right arrow Articles by Gibson, J. M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 54:3547-3553, 2005
© 2005 by the American Diabetes Association, Inc.

Polymorphisms in IGF-Binding Protein 1 Are Associated With Impaired Renal Function in Type 2 Diabetes

Richard H. Stephens1, Patrick McElduff2, Adrian H. Heald1, John P. New1, Jane Worthington3, William E. Ollier4, and J. Martin Gibson1

1 Vascular Research Group, Clinical Sciences Building, Hope Hospital, Salford, U.K.
2 Evidence for Population Health Unit, School of Epidemiology and Health Sciences, University of Manchester, Manchester, U.K.
3 ARC Epidemiology Research Unit, University of Manchester, Manchester, U.K.
4 Centre for Integrated Genomic Medical Research, University of Manchester, Manchester, U.K.

The dysregulation of the IGF system has been implicated in the pathogenesis of obesity, diabetes, and diabetes complications such as nephropathy, but little is known about the genomics of the IGF system in health and disease. We genotyped 13 single nucleotide polymorphisms (SNPs) in IGFBP1 gene in 732 representative type 2 diabetic patients from the Salford Diabetes Register. Of the 13 SNPs, 8 were polymorphic and 7 of those had minor allele frequencies >0.1, one of which was in the gene promoter and one of which was nonsynonymous in exon 4. The minor alleles of these SNPs and two others were associated with a reduced prevalence of diabetic nephropathy. Haplotype analysis revealed that 97% of the genetic variation for IGFBP1 in the population sample could be accounted for using two of the "reno-protective" SNPs, with other SNPs adding little extra information. One of these two SNPs was the nonsynonymous mutation in exon 4, lying close to the integrin-binding RGD motif, which is thought to affect tissue delivery of IGF-I by IGF-binding protein 1 (IGFBP-1), possibly suggesting a "reno-protective" effect via altered IGFBP-1 binding. In conclusion, we have described the first genomic markers to be associated with diabetic microvascular complications within the human IGFBP1 gene.


Address correspondence and reprint requests to Dr. Richard Stephens, Centre for Integrated Genomic Medical Research, University of Manchester, Stopford Bldg., Oxford Road, Manchester, M13 PL, U.K. E-mail: rstephen{at}fs1.ho.man.ac.uk

Abbreviations: ACR, albumin-to-creatinine ratio; GFR, glomerular filtration rate; HIF-1a, hypoxia-inducible transcription factor 1a; HNF-3ß, hepatocyte nuclear factor-3ß; IGFBP, IGF-binding protein; LD, linkage disequilibrium; SNP, single nucleotide polymorphism; USF-1, upstream stimulatory factor 1


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
CJASNHome page
B. I. Freedman, M. Bostrom, P. Daeihagh, and D. W. Bowden
Genetic Factors in Diabetic Nephropathy
Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1306 - 1316.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
S. Pechlivanis, B. Pardini, J. L. Bermejo, K. Wagner, A. Naccarati, L. Vodickova, J. Novotny, K. Hemminki, P. Vodicka, and A. Forsti
Insulin pathway related genes and risk of colorectal cancer: INSR promoter polymorphism shows a protective effect
Endocr. Relat. Cancer, September 1, 2007; 14(3): 733 - 740.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C.-H. Hsieh, K.-H. Liang, Y.-J. Hung, L.-C. Huang, D. Pei, Y.-T. Liao, S.-W. Kuo, M. S.-J. Bey, J.-L. Chen, and E. Y. Chen
Analysis of epistasis for diabetic nephropathy among type 2 diabetic patients
Hum. Mol. Genet., September 15, 2006; 15(18): 2701 - 2708.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. I. Freedman, D. W. Bowden, M. M. Sale, C. D. Langefeld, and S. S. Rich
Genetic Susceptibility Contributes to Renal and Cardiovascular Complications of Type 2 Diabetes Mellitus
Hypertension, July 1, 2006; 48(1): 8 - 13.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2005 by the American Diabetes Association.